RESEARCH ARTICLE


Biological Rhythms in People from North Macedonia with Bipolar Disorder: Application of the Macedonian Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN)



Goce Kalcev1, *, Ivan Barbov2, Pavlina Ilieska Kotevska3, Antonio Preti4, Mauro G. Carta5
1 International Ph.D. in Innovation Sciences and Technologies, University of Cagliari, Cagliari, Italy
2 University Clinic of Neurology, Skopje, North Macedonia
3 Public Health Institution, Psychiatric Hospital Demir Hisar, North Macedonia
4Department of Neuroscience, University of Turin, Italy5Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1072
Abstract HTML Views: 506
PDF Downloads: 447
ePub Downloads: 266
Total Views/Downloads: 2291
Unique Statistics:

Full-Text HTML Views: 683
Abstract HTML Views: 324
PDF Downloads: 327
ePub Downloads: 200
Total Views/Downloads: 1534



Creative Commons License
© 2022 Kalcev et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the International Ph.D. in Innovation Sciences and Technologies, University of Cagliari, Cagliari, Italy; E-mail: gocekalcev@yahoo.com


Abstract

Objective:

The Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN) is a tool aimed at clinically evaluating disturbances in biological rhythm. In this study, we examined the reliability and validity of the Macedonian version of the BRIAN.

Methods:

A total of 100 participants, including 50 subjects with bipolar disorder (BD) and 50 control healthy subjects, were recruited. Construct validity was tested by comparing the mean BRIAN scores of the BD patients and control subjects.

Results:

No difference by gender or age was noticed, but patients differed from controls in education and occupation. Reliability, as measured with Cronbach’s alpha, was good in BD individuals, except for the Rhythms subscale. Reliability in controls was less good, especially for the Sleep and Rhythms subscales. The tool was able to discriminate patients with controls, with large differences on all subscales. However, since the reliability was suboptimal for some of these subscales, these differences cannot be entirely trusted.

Conclusion:

The study suggests that the Macedonian version of this instrument has good psychometric characteristics and also encourages the chance of developing mixed screening tools by incorporating elements of biological rhythm dysregulation into the routine evaluation of mood.

Keywords: Bipolar disorder, BRIAN, Macedonian BRIAN, Disturbances, Biological rhythms, Mood.



1. INTRODUCTION

Bipolar disorder (BD) affects 2-4% of the population and is one of the major causes of disability. The course of bipolar disorder is cyclical and identified by episodes of depression and (hypo)mania with or without mixed features, accompanied by or in the absence of interepisodic euthymia [1]. Alterations in biological rhythms (BR) may have a role in the pathophysiology of BD and may serve as a possible marker in the identification of early stages and relapses of this disturbance as well [2]. Many studies have assumed that identifying the link between biological rhythm disturbances and BD might help better clarify its etiology [3]. Indeed, a vast amount of literature explains the relationship between disruptions of biological rhythms and the maintenance, remission and treatment of bipolar episodes [4-8].

The Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN) was developed to clinically approach disturbances in biological rhythm, especially in patients with mental disorders [9, 10]. Hence, a biological rhythm assessment is not only cardinal for identifying the cause of clinical symptoms but as well for the psychiatric treatment and clinical research of mood disorders. The Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN) is an 18-item interviewer administered instrument that focuses on appraising four main areas related to circadian rhythm disturbance, concretely: sleep, activities, social rhythms and eating patterns. Items are estimated using a 4-point scale, (1)=no difficulty, (2)=mild difficulty, (3)=moderate difficulty, and (4)=severe difficulty. The BRIAN scores, therefore, range from 1 to 72, where the higher scores indicate serious circadian rhythm disturbance [11].

The objective of this study was to examine the reliability and validity of the Macedonian version of the BRIAN by investigating the relevance of the scale for identifying circadian rhythm abnormalities in subjects with BD compared with the healthy subjects in a Macedonian population.

2. MATERIALS AND METHODS

The 1995 Declaration of Helsinki and its revisions [12] have been followed in the carrying on of this study. Approval to the study protocol has been granted by the Institutional Review Board (IRB) of Public Health Institution (PHI)-Psychiatric Hospital Demir Hisar in Demir Hisar and PHI-Psychiatric Hospital Negorci in Negorci, Gevegelija, North Macedonia, with the authorization signed on 15.06.2021 and 13.09.2021, respectively.

2.1. Participants

The study was conducted between May 2021 and October 2021 and included a patient group and a control group.

2.1.1. Patient Group

Individuals who were treated at the Psychiatric Hospitals of Demir Hisar and Negorci, North Macedonia, with a clinician-confirmed diagnosis of bipolar disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM–5) [13], were enrolled in the study. Additional inclusion criteria were: age 18 or over 18 years old and having the capacity of providing informed consent. Exclusion criteria were: non-acceptance to participate in the study (non-signing the informed consent for accepting the participation in the study), patients with another psychiatric diagnosis and the age of the patients less than 18 years.

2.1.2. Control Group

Healthy control subjects were included from the general population upon completion of patient recruitment. Inclusion criteria were: people without psychiatric diagnosis (the absence of symptoms indicating a psychiatric illness was verified by a negative medical history and by a medical interview), on the territory of the Republic of North Macedonia aged 18 or over 18 years old without gender exclusion, with previously signed informed consent. The absence of a personal history of any psychiatric disorder and the absence of a family history of psychiatric disorder in a first-degree relative was another criterium for inclusion in the study. Exclusion criteria were non-acceptance to participate in the study (non-signing the informed consent for accepting the participation in the study) and age less than 18 years. All included subjects provided written informed consent and were invited to fill in the Macedonian version of the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN).

2.2. Measures

A Macedonian version of the BRIAN has been prepared according to standard procedures [14]. The BRIAN was translated into the Macedonian language by a bilingual native editor, then back-translated into English by another bilingual native editor. The final version resulted from a consultation with a third independent researcher, who contributed to harmonizing the translation and back-translation of the BRIAN. The final version was also compared with the previously validated Italian version [9] by a bilingual researcher. The BRIAN includes 18 items and addresses the following dimensions: sleep, activities, social rhythms and eating patterns. The Macedonian version is included in the current paper as Appendix A.

2.3. Statistics

Data were imputed in Excel (Appendix B) and analyzed using the Statistical Package for Social Sciences (SPSS) version 27. All tests were two-tailed, with alpha set at p<0.05. Means with standard deviation, or counts and percentages, were used to describe the distribution of the data in the sample. Unpaired t-test (after Levene correction for inequality of variance) or ANOVA, when appropriate, was used to determine whether continuous variables differed among groups of subjects. Chi-square tests were used for categorical data. Pearson correlation coefficient was used for correlations. Reliability was measured as internal coherence using Cronbach’s alpha. For group comparisons, a rule of thumb assumes that reliability values of 0.70 are considered acceptable [15]. Criterion validity, intended as the degree to which the scores of the instrument were an adequate reflection of a “gold standard” [16], was assessed by comparing the scores of the BRIAN between patients and healthy controls. We expected patients reported higher scores than controls at medium effect size.

A priori power analysis was performed to calculate the minimum sample size to be enrolled to reach the expected effect size in the differences between patients and controls. We calculated that 50 participants per group would have been enough to observe a near medium effect (0.50) in Cohen’s d (standardized mean difference) with alpha set at 0.05 and beta at 0.20 (power = 80%).

2.4. Receiver Operating Characteristics (ROC) Analysis Curve

We used the ROC curve to test the criterion validity of the tools. The degree to which the instrument's scores adequately reflected a “gold standard” was the goal of criterion validity [17]. For this study, we used the clinical diagnosis as a “gold standard” for reference and tested with the ROC curve analysis the capacity of the BRIAN in distinguishing between diagnostic groups. From the analysis, we extracted the following estimates: the sensitivity (the probability of identifying a patient with BD); the specificity (the probability of identifying a patient without BD); the positive predictive value (PPV: the probability that a person is a case of BD when a positive test result is observed); the negative predictive value (NPV: the probability that a person is not a case of BD when a negative test result is observed); and the positive diagnostic likelihood ratio (which is the odds ratio that a positive test will be observed in a population of people with BD compared to the odds that the same result will be observed among a population of people without BD).

The area under the curve (AUC; with 95% confidence interval [CI]) was used to estimate the accuracy of the prediction. Agreed threshold for the AUC was: ≤ .70, poor; between .70 and .80, fair; between .80 and .90, good; above .90, excellent [18]. We used the “pROC” package running in R to perform the ROC analysis [19], while the best cut-off point for the BRIAN was established according to the Youden (1950) [20] method with the “OptimalCutpoints” package [21].

3. RESULTS

No difference by gender or age was noticed (Table 1). Patients differed from controls in education and occupation. These differences are expected because people with bipolar disorder, due to the nature of the disease, have obstacles and limitations in using their potential for higher education levels (university), and also are limited in the constancy in workplaces. Data violated normality for some of the BRIAN scales in patients (Kolmogorov-Smirnov with Lilliefors corrections ‘ s p < 0.05 for Sociality and Rhythms subscales); data violated normality for all BRIAN scales in controls. However, the t-test is pretty robust to depart from the normality assumption.

Reliability, as measured with Cronbach’s alpha, was good in BD subjects, except for the Rhythms subscale; reliability in controls was less good, especially for the Sleep and Rhythms subscales (Table 2).

Table 1. General characteristics of the participants included in the study.
People with Bipolar Disorder Diagnosis People without Psychiatric Disorder Diagnosis Descriptive Statistics
N = 50 N = 50
Gender
Men
Women
28 (56%)
22 (44%)
21 (42%)
29 (58%)
χ2=1,961; df=1; p=0.161;
Age
Mean±Standard deviation
21-30
31-40
41-50
51-60
61-70
48.5±11.1
3 (6%)
8 (16%)
17 (34%)
14 (28%)
8 (16%)
44.8±13.3
10 (20%)
9 (18%)
11(22%)
9 (18%)
11 (22%)
F[1;98]=2.36; p=0.128
HC vs BD by age category:
χ2=6.67; df=1; p=0.154
Education
Compulsory school or less
High school or professional
University degree or higher
13 (26%)
27 (54%)
10 (20%)
4 (8%)
24 (48%)
22 (44%)
χ2=9,441; df=2; p=0.009;
Civil status
Single
Married and cohabiting
Divorced or separated
Widowed
18 (36%)
22 (44%)
8 (16%)
2 (4%)
14 (28%)
28 (56%)
5 (10%)
3 (6%)
χ2=2,112; df=3; p=0.549;
Occupation
Student or housewife
Unemployed
Employed
Retired or disabled
13 (26%)
20 (40%)
16 (32%)
1 (2%)
4 (8%)
12 (24%)
29 (58%)
5 (10%)
χ2=13,187; df=3; p=0.004;
Phase
Depression
Mania or hypomania
Mix status
Euthymia
29 (58%)
13 (26%)
5 (10%)
3 (6%)
- -
Data were expressed as counts and percentages or as mean and standard deviation
Table 2. Reliability statistics.
Control Subjects
Section Cronbach's Alpha Number of Items
Sleep 0.41 5 (1-5)
Activity 0.80 5 (6-10)
Sociality 0.57 4 (11-14)
Eating 0.78 4 (15-18)
Rhythm -0.29 3 (19-21)
Total score 0.77 21 (1-21)
Bipolar disorder subjects
Section Cronbach's Alpha Number of Items
Sleep 0.72 5 (1-5)
Activity 0.92 5 (6-10)
Sociality 0.56 4 (11-14)
Eating 0.92 4 (15-18)
Rhythm -0.14 3 (19-21)
Total score 0.88 21 (1-21)

Table 3. Scores on the five domains of the BRIAN.
Section Control Group Patient Group P T-test dl
Sleep 9.82±2.18 15.06±3.09 0.00 9.78 88.09
Activity 7.78±2.69 14.12±4.37 0.00 8.71 81.51
Sociality 5.58±1.63 10.52±2.55 0.00 11.51 83.17
Eating 6.26±2.49 10.74±4.02 0.00 6.68 81.86
Rhythm 5.94±1.13 6.98±1.33 0.00 4.20 95.51
Total score 35.38±6.63 57.42±11.45 0.00 11.77 78.55
Values are presented in mean±standard deviations.

Furthermore, the tool was able to discriminate patient groups with controls, with large differences on all subscales (Table 3). However, since the reliability was suboptimal for some subscales, these differences cannot be entirely trusted.

The BRIAN distinguished people with high AUC (0.95; 95%CI: 0.91 – 0.99) diagnosed with BD from putatively healthy controls (Fig. 1). The best threshold for the differentiation of BD subjects from controls was 46. Sensitivity and specificity at the best threshold were 86% and 96%. BRIAN showed a poorer NPV (87.3%) than its PPV (95.5%). The positive diagnostic likelihood ratio was high: 21.5. In the investigated samples, just 2 controls (4%), as against 43 patient groups (86%), scored at or above the cut-off on the BRIAN (χ2Yates=64.6; df=1; p<0.0001). The ROC analysis does not assume the normality distribution of the numerical variable.

Fig. (1). ROC analysis curve of Macedonian version of BRIAN.

4. DISCUSSION

We studied the validity and reliability of the Macedonia version of BRIAN, which has been used to measure biological rhythm in psychiatric backgrounds. In particular, individuals with BD, which is known to relate closely with circadian rhythm disturbances, were estimated with control subjects, and a remarkable intergroup difference was verified. The reliability of the Macedonian version of BRIAN, validated through this study, was similar to that determined in earlier studies of BRIAN [22, 23]. The Cronbach’s alpha values for the entire scale and for each subscale were very good and additionally confirmed the good reliability of this tool. Otherwise, the traditional approach of measuring biological rhythm implies continuous measurement of the core body temperature; however, most studies measure behavioral and molecular circadian rhythms [24-26]. Molecular-level assessment may be the most precise; however, this method is invasive and is complex to apply to many subjects [27, 28].

A biological rhythm measurement based on the BRIAN scale is subject to recall bias and dependent on the reliability of answers [29, 30] but can be easily evaluated at any time; furthermore, the ability to assess 5 subdomains makes this scale an attractive clinical and research tool. This result can be interpreted in the context of previous studies, which reported a close relationship between biological rhythm disturbances and more frequent and severe depressive features in patients with BD. In the present study, the BRIAN score was importantly higher in people with BD than in normal control subjects. This is compatible with previous studies putting forward that individuals with BD show more disturbed biological rhythms as determined by the BRIAN [31-35]. Further investigation into the association between the prevalence and intensity of mood symptoms and the BRIAN will be required in the future. This finding contributes important confirmation concerning an approach established on biological rhythms in clinical practices and research of mood disorders. As the main reason for the significant difference in occupation between subjects with bipolar disorder and controls is the reduced ability for consistency and continuity in the workplace, which leads to the loss of the same and obtaining the status of an unemployed person. As well sleep rhythms are thought to depend on the occupation. Moreover, the human circadian rhythm cannot easily adapt to these fast shifts in bipolar disorder. Indeed, in inter-episode bipolar disorder, lower and more variable sleep efficiency and variability in falling asleep time are related to worse illness course and outcome [36]. Relative to the inter-episode phase, sleep disturbance escalates just before an episode, worsens during an episode and does not always resolve with medication [37, 38]

The potential application of this tool based on validity, as a screener, should also be addressed. From this point of view, the authors considered that a screener, in fact, can be convenient if it does not produce false positives and hence is efficient in producing a high predictive value. Actually, if the test is low-priced, noninvasive and adaptable, it can lead to a second evaluation only on positives with a more precise diagnostic tool. It is obvious that this study was conducted by comparing bipolar subjects to people without psychiatric diagnoses. Practically, a screening tool should be able to distinguish, especially among people with various pathologies. From this perspective, it has to look deeper into the fact that the disturbances of biological rhythms have recently been revealed not only in bipolar disorder but as well in other psychiatric disorders such as schizophrenia, autism, major depression, stress related disorders [39-42]. Very interestingly, even on the level of genetic determinants, an association between dysregulation of biological rhythms and bipolar disorder has been observed [43].

The BRIAN showed to be able to distinguish patients diagnosed with BD from putatively healthy controls, with good accuracy (when measured with AUC) and a very good informative positive diagnostic likelihood ratio (around 21). On the basis of the PPV and the NPV, the BRIAN is a screener that is good at confirming the presence of a BD, although it can also contribute to excluding its presence.

Few studies applied the receiver operating characteristic curve (ROC) to the BRIAN to determine its screening capacity. In a study on 60 newly diagnosed Japanese patients with delayed sleep-wake phase disorder, a threshold of 40 on the BRIAN discriminated patients from controls with a sensitivity of 80.0% and a specificity of 75.6% [44]. Since the study was on a condition different from BD, we cannot compare the threshold we have found with the one of the Japanese studies. On the other hand, the study of validation of the Italian version of BRIAN showed good accuracy in screening between BD (44 subjects) and non-BD (38 subjects). It was noticed quite good performance in specificity, for example, at cutoff 16, with a sensitivity of 68.2% and excellent specificity of 92.5% [9].

5. LIMITATIONS

The limited sample size and the preliminary nature of the data represent obvious limitations of the study, which was designed to validate the Macedonian version of the BRIAN, not to test its screening effects. Despite their preliminary nature, the reported findings purport an innovative approach in the development of screening tools aimed at detecting the consequences of the symptoms (on circadian rhythms) rather than simply counting their occurrence. As evidenced by past studies, the tool emerges as a very practical tool for evaluating the bipolar disorder phenotype because it focuses on biological rhythms, contrasting other scales that only indirectly consider biological rhythm by evaluating seasonality or chronotype. In the future, this version of the scale will probably be used for biological rhythm measurements in different psychiatric areas and for active research and clinical practice concerning mood disorders.

CONCLUSION

Due to the significance of monitoring biological rhythms with a relevant and consistent instrument, BRIAN can be an applicable tool both in research and clinical practice with bipolar patients. The study suggests that the Macedonian version of this instrument has acceptable psychometric characteristics and also encourages the chance of developing mixed screening tools by incorporating elements of biological rhythm dysregulation into the routine evaluation of mood.

LIST OF ABBREVIATIONS

BRIAN = Biological Rhythms Interview of Assessment in Neuropsychiatry
BD = Bipolar Disorder

AUTHORS' CONTRIBUTIONS

GK has prepared the first draft; GK and AP prepared the statistical analysis, IB, PIK, AP, MGC revised it. All authors approved the final version of the paper.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Approval to the study protocol has been granted by the Institutional Review Board (IRB) of Public Health Institution (PHI)-Psychiatric Hospital Demir Hisar in Demir Hisar and PHI-Psychiatric Hospital Negorci in Negorci, Gevegelija, North Macedonia, with the authorization signed on 15.06.2021 and 13.09.2021, respectively.

HUMAN AND ANIMAL RIGHTS

No animals were used for studies that are the basis of this research. All the humans were used in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013 (http://ethics.iit.edu/ecodes/node/3931).

CONSENT FOR PUBLICATION

Informed consent was obtained from all participants of this study.

STANDARDS OF REPORTING

STROBE guidelines were followed.

AVAILABILITY OF DATA AND MATERIALS

The dataset that supports the results and findings of this research is available from the corresponding author [G.K.] upon reasonable request.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflicts of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Goce Kalcev (MD) participated in the writing of this paper within the framework of the International Ph.D. in Innovation Sciences and Technologies at the University of Cagliari, Italy.

REFERENCES

[1] Carta M, Angst J. Epidemiological and clinical aspects of bipolar disorders: Controversies or a common need to redefine the aims and methodological aspects of surveys. Clin Pract Epidemiol Ment Health 2005; 1(1): 4.
[2] Esaki Y, Obayashi K, Saeki K, Fujita K, Iwata N, Kitajima T. Association between circadian activity rhythms and mood episode relapse in bipolar disorder: A 12-month prospective cohort study. Transl Psychiatry 2021; 11(1): 525.
[3] Arnold I, Dehning J, Grunze A, Hausmann A. Old Age Bipolar Disorder—Epidemiology, Aetiology and Treatment. Medicina (Kaunas) 2021; 57(6): 587.
[4] Li J, Lu WQ, Beesley S, Loudon ASI, Meng QJ. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One 2012; 7(3)e33292
[5] Carta MG, Fanni D, Orrù G, Faa G. Commentary: Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms. Front Psychiatry 2021; 12730360
[6] Carta MG, Fornaro M, Minerba L, et al. Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults. J Public Health Res 2022; 11(2)jphr.2022.2768
[7] Bengesser SA, Reininghaus EZ, Lackner N, et al. Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL. World J Biol Psychiatry 2018; 19(2): S21-9.
[8] Carta MG, Bhat KM, Preti A. GABAergic neuroactive steroids: A new frontier in bipolar disorders? Behav Brain Funct 2012; 8(1): 61.
[9] Moro MF, Carta MG, Pintus M, et al. Validation of the Italian Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN): Some considerations on its screening usefulness. Clin Pract Epidemiol Ment Health 2014; 10(1): 48-52.
[10] Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381(9878): 1672-82.
[11] Giglio LM, Magalhães PVS, Kapczinski NS, Walz JC, Kapczinski F. Functional impact of biological rhythm disturbance in bipolar disorder. J Psychiatr Res 2010; 44(4): 220-3.
[12] World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310(20): 2191-4.
[13] American Psychiatric Association. Cautionary statement for forensic use of DSM-5 In Diagnostic and statistical manual of mental disorders 2013.
[14] Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 1993; 46(12): 1417-32.
[15] Nunnally JC, Bernstein IH. The Assessment of Reliability. Psychometric Theory 1994; 3: 248-92.
[16] Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: An international Delphi study. Qual Life Res 2010; 19(4): 539-49.
[17] Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010; 63(7): 737-45.
[18] Hosmer DW, Lemeshow S. Applied Logistic Regression 2nd ed. 2000; 160-4.
[19] Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12(1): 77.
[20] Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3(1): 32-5.
[21] López-Ratón M, Rodríguez-Álvarez MX, Suárez CC, Sampedro FG. Optimal cutpoints: An R package for selecting optimal cutpoints in diagnostic tests. J Stat Softw 2014; 61(8): 1-36.
[22] Giglio LMF, Magalhães PVS, Andreazza AC, et al. Development and use of a biological rhythm interview. J Affect Disord 2009; 118(1-3): 161-5.
[23] Cho CH, Jung SY, Kapczinski F, Rosa AR, Lee HJ. Validation of the Korean Version of the Biological Rhythms Interview of Assessment in Neuropsychiatry. Psychiatry Investig 2018; 15(12): 1115-20.
[24] Cho CH, Moon JH, Yoon HK, et al. Molecular circadian rhythm shift due to bright light exposure before bedtime is related to subthreshold bipolarity. Sci Rep 2016; 6(1): 31846.
[25] Son GH, Chung S, Choe HK, et al. Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc Natl Acad Sci USA 2008; 105(52): 20970-5.
[26] Inouye ST, Kawamura H. Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 1979; 76(11): 5962-6.
[27] Lee HA, Lee HJ, Moon JH, et al. Comparison of wearable activity tracker with actigraphy for sleep evaluation and circadian rest-activity rhythm measurement in healthy young adults. Psychiatry Investig 2017; 14(2): 179-85.
[28] Morgenthaler T, Alessi C, Friedman L, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: An update for 2007. Sleep 2007; 30(4): 519-29.
[29] Van de Mortel TF. Faking it: social desirability response bias in self-report research. Aust J Adv Nurs 2008; 25: 40-8.
[30] Wherry RJ Sr, Bartlett CJ. The control of bias in ratings: A theory of rating. Person Psychol 1982; 35(3): 521-51.
[31] Vadnie CA, McClung CA. Circadian rhythm disturbances in mood disorders: insights into the role of the suprachiasmatic nucleus. Neural Plast 2017; 2017: 1-28.
[32] Rosa AR, Comes M, Torrent C, et al. Biological rhythm disturbance in remitted bipolar patients. Int J Bipolar Disord 2013; 1(1): 6.
[33] Moon JH, Cho CH, Son GH, et al. Advanced circadian phase in mania and delayed circadian phase in mixed mania and depression returned to normal after treatment of bipolar disorder. EBioMedicine 2016; 11: 285-95.
[34] Carta MG, Ouali U, Perra A, et al. Living with bipolar disorder in the time of Covid-19: Biorhythms during the severe lockdown in cagliari, italy, and the moderate lockdown in tunis, tunisia. Front Psychiatry 2021; 12634765
[35] Robillard R, Naismith SL, Hickie IB. Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder. Curr Psychiatry Rep 2013; 15(10): 402.
[36] Eidelman P, Talbot LS, Gruber J, Harvey AG. Sleep, illness course, and concurrent symptoms in inter-episode bipolar disorder. J Behav Ther Exp Psychiatry 2010; 41(2): 145-9.
[37] Wehr TA, Sack DA, Rosenthal NE. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987; 144(2): 201-4.
[38] Jackson A, Cavanagh J, Scott J. A systematic review of manic and depressive prodromes. J Affect Disord 2003; 74(3): 209-17.
[39] Waddington Lamont E, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci 2007; 9(3): 333-42.
[40] McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007; 114(2): 222-32.
[41] Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders Cold Spring Harbor Symposium on Quantum Biology 2007; 645-54.
[42] Carta M, Balestrieri M, Murru A, Hardoy M. Adjustment Disorder: Epidemiology, diagnosis and treatment. Clin Pract Epidemiol Ment Health 2009; 5(1): 15.
[43] Prasko J. Bright light therapy. Neuroendocrinol Lett 2008; 29(Suppl. 1): 33-64.
[44] Kanda Y, Takaesu Y, Kobayashi M, et al. Reliability and validity of the Japanese version of the Biological Rhythms Interview of assessment in neuropsychiatry-self report for delayed sleep-wake phase disorder. Sleep Med 2021; 81: 288-93.